RxDoctor Payments DataLook up a doctor →

Daniel Zuckerbrod, MD

Ophthalmology · Detroit, MINPI 1033104773

Payments from drug & device makers

$16,574in general payments, 2019–2025

Across 650 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alimera Sciences, Inc.$4K
  • AbbVie$3K
  • Alcon$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Bausch & Lomb Americas Inc.$912
  • Aerie Pharmaceuticals, Inc.$801
  • plus $5K from 29 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$16,574 in reported general payments places this provider in the 90th percentile of 674 ophthalmology providers in Michigan.

See all ophthalmology providers in Michigan

Medicare billing

Part B allowed, 2024
$504,059
Medicare patients
515
Services billed
5,957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →